BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11941539)

  • 1. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.
    Rökman A; Ikonen T; Seppälä EH; Nupponen N; Autio V; Mononen N; Bailey-Wilson J; Trent J; Carpten J; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
    Am J Hum Genet; 2002 May; 70(5):1299-304. PubMed ID: 11941539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer.
    Wiklund F; Jonsson BA; Brookes AJ; Strömqvist L; Adolfsson J; Emanuelsson M; Adami HO; Augustsson-Bälter K; Grönberg H
    Clin Cancer Res; 2004 Nov; 10(21):7150-6. PubMed ID: 15534086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.
    Carpten J; Nupponen N; Isaacs S; Sood R; Robbins C; Xu J; Faruque M; Moses T; Ewing C; Gillanders E; Hu P; Bujnovszky P; Makalowska I; Baffoe-Bonnie A; Faith D; Smith J; Stephan D; Wiley K; Brownstein M; Gildea D; Kelly B; Jenkins R; Hostetter G; Matikainen M; Schleutker J; Klinger K; Connors T; Xiang Y; Wang Z; De Marzo A; Papadopoulos N; Kallioniemi OP; Burk R; Meyers D; Grönberg H; Meltzer P; Silverman R; Bailey-Wilson J; Walsh P; Isaacs W; Trent J
    Nat Genet; 2002 Feb; 30(2):181-4. PubMed ID: 11799394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ-line alterations in MSR1 gene and prostate cancer risk.
    Seppälä EH; Ikonen T; Autio V; Rökman A; Mononen N; Matikainen MP; Tammela TL; Schleutker J
    Clin Cancer Res; 2003 Nov; 9(14):5252-6. PubMed ID: 14614006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.
    Maier C; Haeusler J; Herkommer K; Vesovic Z; Hoegel J; Vogel W; Paiss T
    Br J Cancer; 2005 Mar; 92(6):1159-64. PubMed ID: 15714208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of germline MLH1 alterations in familial prostate cancer.
    Fredriksson H; Ikonen T; Autio V; Matikainen MP; Helin HJ; Tammela TL; Koivisto PA; Schleutker J
    Eur J Cancer; 2006 Nov; 42(16):2802-6. PubMed ID: 16963262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
    Rökman A; Ikonen T; Mononen N; Autio V; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
    Cancer Res; 2001 Aug; 61(16):6038-41. PubMed ID: 11507049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population.
    Nakazato H; Suzuki K; Matsui H; Ohtake N; Nakata S; Yamanaka H
    Br J Cancer; 2003 Aug; 89(4):691-6. PubMed ID: 12915880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
    Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi OP
    Clin Cancer Res; 2000 Dec; 6(12):4810-5. PubMed ID: 11156239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the RNASEL gene in familial and sporadic prostate cancer.
    Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Am J Hum Genet; 2002 Jul; 71(1):116-23. PubMed ID: 12022038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.
    Casey G; Neville PJ; Plummer SJ; Xiang Y; Krumroy LM; Klein EA; Catalona WJ; Nupponen N; Carpten JD; Trent JM; Silverman RH; Witte JS
    Nat Genet; 2002 Dec; 32(4):581-3. PubMed ID: 12415269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline copy number variation analysis in Finnish families with hereditary prostate cancer.
    Laitinen VH; Akinrinade O; Rantapero T; Tammela TL; Wahlfors T; Schleutker J
    Prostate; 2016 Feb; 76(3):316-24. PubMed ID: 26552734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.
    Krüger S; Silber AS; Engel C; Görgens H; Mangold E; Pagenstecher C; Holinski-Feder E; von Knebel Doeberitz M; Moeslein G; Dietmaier W; Stemmler S; Friedl W; Rüschoff J; Schackert HK;
    Lancet Oncol; 2005 Aug; 6(8):566-72. PubMed ID: 16054567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications for RNase L in prostate cancer biology.
    Silverman RH
    Biochemistry; 2003 Feb; 42(7):1805-12. PubMed ID: 12590567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
    Nupponen NN; Wallén MJ; Ponciano D; Robbins CM; Tammela TL; Vessella RL; Carpten JD; Visakorpi T
    Genes Chromosomes Cancer; 2004 Feb; 39(2):119-25. PubMed ID: 14695991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma.
    Noonan-Wheeler FC; Wu W; Roehl KA; Klim A; Haugen J; Suarez BK; Kibel AS
    Prostate; 2006 Jan; 66(1):49-56. PubMed ID: 16114055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of HPC2/ELAC2 in hereditary prostate cancer.
    Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Cancer Res; 2001 Sep; 61(17):6494-9. PubMed ID: 11522646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer.
    Agalliu I; Kwon EM; Zadory D; McIntosh L; Thompson J; Stanford JL; Ostrander EA
    Clin Cancer Res; 2007 Feb; 13(3):839-43. PubMed ID: 17289875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.
    Xu J
    Am J Hum Genet; 2000 Mar; 66(3):945-57. PubMed ID: 10712209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.